Fekrirad Z, Gharedaghi M, Saadatpour F, Molabashi Z, Rezayof A, Korourian A
Heliyon. 2024; 10(17):e37041.
PMID: 39286083
PMC: 11403485.
DOI: 10.1016/j.heliyon.2024.e37041.
Obrador E, Moreno-Murciano P, Oriol-Caballo M, Lopez-Blanch R, Pineda B, Gutierrez-Arroyo J
Int J Mol Sci. 2024; 25(5).
PMID: 38473776
PMC: 10931797.
DOI: 10.3390/ijms25052529.
Valle-Garcia D, la Cruz V, Flores I, Salazar A, Pineda B, Meza-Sosa K
Int J Mol Sci. 2024; 25(5).
PMID: 38473710
PMC: 10931459.
DOI: 10.3390/ijms25052464.
Singh R, Mondal I, Janjua T, Popat A, Kulshreshtha R
Bioact Mater. 2023; 33:396-423.
PMID: 38059120
PMC: 10696434.
DOI: 10.1016/j.bioactmat.2023.11.007.
Wang M, Wang X, Jin X, Zhou J, Zhang Y, Yang Y
Front Immunol. 2023; 14:1175118.
PMID: 37304305
PMC: 10248152.
DOI: 10.3389/fimmu.2023.1175118.
Anti-tumor effects of miR-34a by regulating immune cells in the tumor microenvironment.
Yin M, Zhang Z, Wang Y
Cancer Med. 2023; 12(10):11602-11610.
PMID: 36951490
PMC: 10242310.
DOI: 10.1002/cam4.5826.
The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.
Gheidari F, Arefian E, Saadatpour F, Kabiri M, Seyedjafari E, Teimoori-Toolabi L
Mol Biol Rep. 2022; 49(12):11855-11866.
PMID: 36219319
DOI: 10.1007/s11033-022-07903-2.
Novel approaches to combat chemoresistance against glioblastomas.
Towner R, Zalles M, Saunders D, Smith N
Cancer Drug Resist. 2022; 3(4):686-698.
PMID: 35582224
PMC: 8992560.
DOI: 10.20517/cdr.2020.38.
The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
Wanjiku Macharia L, Muriithi W, Pilotto Heming C, Nyaga D, Aran V, Mureithi M
BMC Cancer. 2021; 21(1):1248.
PMID: 34798868
PMC: 8605580.
DOI: 10.1186/s12885-021-08978-z.
Role of microRNAs in glioblastoma.
Chen M, Medarova Z, Moore A
Oncotarget. 2021; 12(17):1707-1723.
PMID: 34434499
PMC: 8378762.
DOI: 10.18632/oncotarget.28039.
Long non-coding RNA TUG1 knockdown hinders the tumorigenesis of multiple myeloma by regulating the microRNA-34a-5p/NOTCH1 signaling pathway.
Zhang Y, Zhao D, Li S, Xiao M, Zhou H, Yang S
Open Life Sci. 2021; 15(1):284-295.
PMID: 33817217
PMC: 7874539.
DOI: 10.1515/biol-2020-0025.
Antioxidative effects of polypyrimidine tract-binding protein-associated splicing factor against pathological retinal angiogenesis through promotion of mitochondrial function.
Dong L, Lin T, Li W, Hong Y, Ren X, Ke Y
J Mol Med (Berl). 2021; 99(7):967-980.
PMID: 33770188
DOI: 10.1007/s00109-021-02069-z.
KLF6 Induces Apoptosis in Human Lens Epithelial Cells Through the ATF4-ATF3-CHOP Axis.
Tian F, Zhao J, Bu S, Teng H, Yang J, Zhang X
Drug Des Devel Ther. 2020; 14:1041-1055.
PMID: 32210535
PMC: 7069589.
DOI: 10.2147/DDDT.S218467.
Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN.
Wang B, Wu Z, Lou P, Chai C, Han S, Ning J
Cell Oncol (Dordr). 2019; 42(6):783-799.
PMID: 31332647
DOI: 10.1007/s13402-019-00461-z.
Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors.
Basso J, Miranda A, Nunes S, Cova T, Sousa J, Vitorino C
Gels. 2019; 4(3).
PMID: 30674838
PMC: 6209281.
DOI: 10.3390/gels4030062.
miR-34a in Neurophysiology and Neuropathology.
Chua C, Tang B
J Mol Neurosci. 2018; 67(2):235-246.
PMID: 30488149
DOI: 10.1007/s12031-018-1231-y.
miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein.
Long Y, Liu X, Chen S, Zong D, Chen Y, Chen P
Respir Res. 2018; 19(1):21.
PMID: 29373969
PMC: 5787261.
DOI: 10.1186/s12931-018-0722-2.
Deregulation of miR-34a and Its Chaperon Hsp70 in Hepatitis C virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma Patients.
Shehata R, Abdelmoneim S, Osman O, Hasanain A, Osama A, Abdelmoneim S
Asian Pac J Cancer Prev. 2017; 18(9):2395-2401.
PMID: 28950684
PMC: 5720642.
DOI: 10.22034/APJCP.2017.18.9.2395.
MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling.
Zhang X, Ai F, Li X, Tian L, Wang X, Shen S
Oncol Lett. 2017; 14(2):2325-2333.
PMID: 28781671
PMC: 5530141.
DOI: 10.3892/ol.2017.6444.
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma.
Bettinsoli P, Ferrari-Toninelli G, Bonini S, Prandelli C, Memo M
BMC Cancer. 2017; 17(1):352.
PMID: 28525978
PMC: 5438559.
DOI: 10.1186/s12885-017-3340-3.